UMY-11834-14537
3 vaccinations
1 coded response
28 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 532 / WI
- Registered
- 2021-06-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
H3U-26988-83664
Child or adolescent in my care · Female · 2022-06-27
Timeline
-
2021-06-16
Dose 1 — Pfizer-BioNTech
-
2021-06-21
Registered in v-safe
- 2021-06-21
- 2021-06-22
- 2021-06-23
- 2021-06-30
-
2021-07-07
Dose 2 — Pfizer-BioNTech
- 2021-07-07
- 2021-07-08
- 2021-07-09
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-21
- 2021-07-28
- 2021-08-04
- 2021-08-11
- 2021-08-18
- 2021-10-06
-
2022-01-07
Dose 3 — Moderna
- 2022-01-07
-
2022-01-08
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Cold like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-12
- 2022-01-13
- 2022-01-21
- 2022-01-30
- 2022-02-04
- 2022-02-11
- 2022-02-20
- 2022-04-08
- 2022-07-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-16 | Pfizer-BioNTech | No |
| 2 | 2021-07-07 | Pfizer-BioNTech | No |
| 3 | 2022-01-07 | Moderna | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Cold like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release